Skip to Navigation Skip to Search Skip to Content
Search All Centers

Expanded Treatment Options for Relapsed/Refractory Hodgkin Lymphoma

For the 10% of patients that experience a Hodgkin lymphoma relapse, there is now a large toolbox full of treatment options, including allogeneic transplants if an autologous transplant is unsuccessful.  Dr. John Sweetenham and physician's assistant John Sayler discuss treatment approaches and  the goal of developing  techniques that will maintain and improve cure rates , while reducing the long-term risk of additional complications from treatment. 

Featuring